News & Resources
J&J Stops Selling Four Brands of Vaginal Mesh Implants
Ethicon Inc., a wholly owned subsidiary of Johnson & Johnson, has decided to cease marketing and producing four types of vaginal mesh implants.
The U.S. Food and Drug Administration have released a report raising new concerns about the serious side effects caused by a class of osteoporosis drugs called Bisphosphonates.
A new FDA proposal to change the classification of several prescription medications to over-the-counter (OTC) status seems to put pharmaceutical companies’ profits before patient safety.
The U.S. Supreme Court ruling in June of 2011 in the case of Pliva v. Mensing had devastating consequences for a vast number of consumers injured by generic drugs.
On March 21, 2012, Bloomberg reported the news that Johnson & Johnson's Ethicon unit sold a particular vaginal mesh product called Gynecare Prolift for three years before obtaining proper FDA approval in 2008.
